Skip to content

Insulet

NASDAQ: PODD · USD

Insulet financials

6 charts

Revenue

USD millions

$801.7M
Insulet Revenue. Quarterly values and changes versus the preceding comparable period. Missing values are unavailable.
PeriodRevenue
FY 2011 Q2$32.211M; Change unavailable vs FY 2011 Q1
FY 2011 Q3$44.594M; +38.4% vs FY 2011 Q2
FY 2011 Q4$47.192M; +5.8% vs FY 2011 Q3
FY 2012 Q1$47.754M; +1.2% vs FY 2011 Q4
FY 2012 Q2$51.035M; +6.9% vs FY 2012 Q1
FY 2012 Q3$54.752M; +7.3% vs FY 2012 Q2
FY 2012 Q4$57.828M; +5.6% vs FY 2012 Q3
FY 2013 Q1$57.356M; −0.8% vs FY 2012 Q4
FY 2013 Q2$60.092M; +4.8% vs FY 2013 Q1
FY 2013 Q3$61.103M; +1.7% vs FY 2013 Q2
FY 2013 Q4$68.533M; +12.2% vs FY 2013 Q3
FY 2014 Q1$69.161M; +0.9% vs FY 2013 Q4
FY 2014 Q2$72.013M; +4.1% vs FY 2014 Q1
FY 2014 Q3$74.985M; +4.1% vs FY 2014 Q2
FY 2014 Q4$72.561M; −3.2% vs FY 2014 Q3
FY 2015 Q1$61.215M; −15.6% vs FY 2014 Q4
FY 2015 Q2$75.588M; +23.5% vs FY 2015 Q1
FY 2015 Q3$87.303M; +15.5% vs FY 2015 Q2
FY 2015 Q4$100.119M; +14.7% vs FY 2015 Q3
FY 2016 Q1$81.213M; −18.9% vs FY 2015 Q4
FY 2016 Q2$87.33M; +7.5% vs FY 2016 Q1
FY 2016 Q3$94.871M; +8.6% vs FY 2016 Q2
FY 2016 Q4$103.575M; +9.2% vs FY 2016 Q3
FY 2017 Q1$101.713M; −1.8% vs FY 2016 Q4
FY 2017 Q2$109.756M; +7.9% vs FY 2017 Q1
FY 2017 Q3$121.775M; +11.0% vs FY 2017 Q2
FY 2017 Q4$130.524M; +7.2% vs FY 2017 Q3
FY 2018 Q1$123.578M; −5.3% vs FY 2017 Q4
FY 2018 Q2$124.262M; +0.6% vs FY 2018 Q1
FY 2018 Q3$151.076M; +21.6% vs FY 2018 Q2
FY 2018 Q4$164.907M; +9.2% vs FY 2018 Q3
FY 2019 Q1$159.555M; −3.2% vs FY 2018 Q4
FY 2019 Q2$177.136M; +11.0% vs FY 2019 Q1
FY 2019 Q3$192.115M; +8.5% vs FY 2019 Q2
FY 2019 Q4$209.4M; +9.0% vs FY 2019 Q3
FY 2020 Q1$198M; −5.4% vs FY 2019 Q4
FY 2020 Q2$226.3M; +14.3% vs FY 2020 Q1
FY 2020 Q3$234M; +3.4% vs FY 2020 Q2
FY 2020 Q4$246.1M; +5.2% vs FY 2020 Q3
FY 2021 Q1$252.3M; +2.5% vs FY 2020 Q4
FY 2021 Q2$263.2M; +4.3% vs FY 2021 Q1
FY 2021 Q3$275.6M; +4.7% vs FY 2021 Q2
FY 2021 Q4$307.7M; +11.6% vs FY 2021 Q3
FY 2022 Q1$247M; −19.7% vs FY 2021 Q4
FY 2022 Q2$243.9M; −1.3% vs FY 2022 Q1
FY 2022 Q3$281.9M; +15.6% vs FY 2022 Q2
FY 2022 Q4$282.6M; +0.2% vs FY 2022 Q3
FY 2023 Q1$261.3M; −7.5% vs FY 2022 Q4
FY 2023 Q2$396.5M; +51.7% vs FY 2023 Q1
FY 2023 Q3$432.7M; +9.1% vs FY 2023 Q2
FY 2023 Q4$509.8M; +17.8% vs FY 2023 Q3
FY 2024 Q1$441.7M; −13.4% vs FY 2023 Q4
FY 2024 Q2$488.5M; +10.6% vs FY 2024 Q1
FY 2024 Q3$543.9M; +11.3% vs FY 2024 Q2
FY 2024 Q4$597.5M; +9.9% vs FY 2024 Q3
FY 2025 Q1$569M; −4.8% vs FY 2024 Q4
FY 2025 Q2$649.1M; +14.1% vs FY 2025 Q1
FY 2025 Q3$706.3M; +8.8% vs FY 2025 Q2
FY 2025 Q4$783.8M; +11.0% vs FY 2025 Q3
FY 2026 Q1$761.7M; −2.8% vs FY 2025 Q4
FY 2026 Q2$801.7M; +5.3% vs FY 2026 Q1
Jun 30, 2011 through Sep 25, 2026

Free cash flow

USD millions

$55.9M
Insulet Free cash flow. Quarterly values and changes versus the preceding comparable period. Missing values are unavailable.
PeriodFree cash flow
FY 2011 Q2$-11.745M; Change unavailable vs FY 2011 Q1
FY 2011 Q3$-4.114M; +65.0% vs FY 2011 Q2
FY 2011 Q4$-9.944M; −141.7% vs FY 2011 Q3
FY 2012 Q1$-10.602M; −6.6% vs FY 2011 Q4
FY 2012 Q2$-13.664M; −28.9% vs FY 2012 Q1
FY 2012 Q3$-8.136M; +40.5% vs FY 2012 Q2
FY 2012 Q4$-7.648M; +6.0% vs FY 2012 Q3
FY 2013 Q1$-2.269M; +70.3% vs FY 2012 Q4
FY 2013 Q2$2.746M; +221.0% vs FY 2013 Q1
FY 2013 Q3$1.872M; −31.8% vs FY 2013 Q2
FY 2013 Q4$-6.308M; −437.0% vs FY 2013 Q3
FY 2014 Q1$-3.174M; +49.7% vs FY 2013 Q4
FY 2014 Q2$-3.08M; +3.0% vs FY 2014 Q1
FY 2014 Q3$1.714M; +155.6% vs FY 2014 Q2
FY 2014 Q4$1.974M; +15.2% vs FY 2014 Q3
FY 2015 Q1$-7.834M; −496.9% vs FY 2014 Q4
FY 2015 Q2$0.53M; +106.8% vs FY 2015 Q1
FY 2015 Q3$6.221M; +1073.8% vs FY 2015 Q2
FY 2015 Q4$-22.077M; −454.9% vs FY 2015 Q3
FY 2016 Q1$-13.677M; +38.0% vs FY 2015 Q4
FY 2016 Q2$0.936M; +106.8% vs FY 2016 Q1
FY 2016 Q3$-10.623M; −1234.9% vs FY 2016 Q2
FY 2016 Q4$17.16M; +261.5% vs FY 2016 Q3
FY 2017 Q1$-47.514M; −376.9% vs FY 2016 Q4
FY 2017 Q2$4.575M; +109.6% vs FY 2017 Q1
FY 2017 Q3$14.533M; +217.7% vs FY 2017 Q2
FY 2017 Q4$-7.613M; −152.4% vs FY 2017 Q3
FY 2018 Q1$-39.64M; −420.7% vs FY 2017 Q4
FY 2018 Q2$-60.692M; −53.1% vs FY 2018 Q1
FY 2018 Q3$-21.767M; +64.1% vs FY 2018 Q2
FY 2018 Q4$-4.356M; +80.0% vs FY 2018 Q3
FY 2019 Q1$-38.888M; −792.7% vs FY 2018 Q4
FY 2019 Q2$-32.784M; +15.7% vs FY 2019 Q1
FY 2019 Q3$8.554M; +126.1% vs FY 2019 Q2
FY 2019 Q4$-2.182M; −125.5% vs FY 2019 Q3
FY 2020 Q1$-30.5M; −1297.8% vs FY 2019 Q4
FY 2020 Q2$1.6M; +105.2% vs FY 2020 Q1
FY 2020 Q3$25.4M; +1487.5% vs FY 2020 Q2
FY 2020 Q4$-41.5M; −263.4% vs FY 2020 Q3
FY 2021 Q1$-68M; −63.9% vs FY 2020 Q4
FY 2021 Q2$-1.6M; +97.6% vs FY 2021 Q1
FY 2021 Q3$-53.1M; −3218.8% vs FY 2021 Q2
FY 2021 Q4$-57.3M; −7.9% vs FY 2021 Q3
FY 2022 Q1$-26.5M; +53.8% vs FY 2021 Q4
FY 2022 Q2$10.7M; +140.4% vs FY 2022 Q1
FY 2022 Q3$25.6M; +139.3% vs FY 2022 Q2
FY 2022 Q4$-13.7M; −153.5% vs FY 2022 Q3
FY 2023 Q1$-10M; +27.0% vs FY 2022 Q4
FY 2023 Q2$28.3M; +383.0% vs FY 2023 Q1
FY 2023 Q3$35.9M; +26.9% vs FY 2023 Q2
FY 2023 Q4$15.9M; −55.7% vs FY 2023 Q3
FY 2024 Q1$65.5M; +311.9% vs FY 2023 Q4
FY 2024 Q2$74M; +13.0% vs FY 2024 Q1
FY 2024 Q3$71.8M; −3.0% vs FY 2024 Q2
FY 2024 Q4$94.1M; +31.1% vs FY 2024 Q3
FY 2025 Q1$51.5M; −45.3% vs FY 2024 Q4
FY 2025 Q2$177.9M; +245.4% vs FY 2025 Q1
FY 2025 Q3$100.1M; −43.7% vs FY 2025 Q2
FY 2025 Q4$48.2M; −51.8% vs FY 2025 Q3
FY 2026 Q1$89.5M; +85.7% vs FY 2025 Q4
FY 2026 Q2$55.9M; −37.5% vs FY 2026 Q1

Net margin

%

11.85%
Insulet Net margin. Reported fiscal history.
Fiscal period%
FY 2011 Q2-60.3%
FY 2011 Q3-30.41%
FY 2011 Q4-30.38%
FY 2012 Q1-30.95%
FY 2012 Q2-28.36%
FY 2012 Q3-22.68%
FY 2012 Q4-17.63%
FY 2013 Q1-18.59%
FY 2013 Q2-17.5%
FY 2013 Q3-34.84%
FY 2013 Q4-3.65%
FY 2014 Q1-8.88%
FY 2014 Q2-40.42%
FY 2014 Q3-14.46%
FY 2014 Q4-7.44%
FY 2015 Q1-19.33%
FY 2015 Q2-20.42%
FY 2015 Q3-21.68%
FY 2015 Q4-27.29%
FY 2016 Q1-15.37%
FY 2016 Q2-4.81%
FY 2016 Q3-3.25%
FY 2016 Q4-8.8%
FY 2017 Q1-9.81%
FY 2017 Q2-7.08%
FY 2017 Q3-1.83%
FY 2017 Q4-5.26%
FY 2018 Q1-5.32%
FY 2018 Q2-1.36%
FY 2018 Q31.1%
FY 2018 Q46%
FY 2019 Q12.74%
FY 2019 Q20.79%
FY 2019 Q30.44%
FY 2019 Q42.39%
FY 2020 Q1-1.06%
FY 2020 Q26.36%
FY 2020 Q34.96%
FY 2020 Q4-6.95%
FY 2021 Q10%
FY 2021 Q2-9.5%
FY 2021 Q34.57%
FY 2021 Q49.49%
FY 2022 Q111.26%
FY 2022 Q2-14.35%
FY 2022 Q3-1.84%
FY 2022 Q46.02%
FY 2023 Q19.11%
FY 2023 Q26.89%
FY 2023 Q311.99%
FY 2023 Q420.26%
FY 2024 Q111.66%
FY 2024 Q238.61%
FY 2024 Q314.25%
FY 2024 Q416.85%
FY 2025 Q16.22%
FY 2025 Q23.47%
FY 2025 Q312.4%
FY 2025 Q412.96%
FY 2026 Q111.96%
FY 2026 Q211.85%

P/E

× · TTM · Daily

25.17×
Insulet P/E. Monthly closing observations; inspect daily values with the chart arrow keys.
Close date× · TTM · DailyFinancials through
2018-11-30—2017-09-30
2018-12-31—2017-09-30
2019-01-31—2017-09-30
2019-02-28—2017-09-30
2019-03-29—2017-09-30
2019-04-30—2017-09-30
2019-05-31—2017-09-30
2019-06-28—2017-09-30
2019-07-31—2017-09-30
2019-08-30—2017-09-30
2019-09-30—2017-09-30
2019-10-31—2017-09-30
2019-11-29—2017-09-30
2019-12-31—2017-09-30
2020-01-31—2017-09-30
2020-02-28—2018-09-30
2020-03-31—2018-09-30
2020-04-30—2018-09-30
2020-05-292,300.73×2020-03-31
2020-06-302,370.16×2020-03-31
2020-07-312,481.18×2020-03-31
2020-08-31788.48×2020-06-30
2020-09-30854.74×2020-06-30
2020-10-30802.93×2020-06-30
2020-11-30595.92×2020-09-30
2020-12-31591.11×2020-09-30
2021-01-29617.82×2020-09-30
2021-02-262,552.21×2020-12-31
2021-03-312,570.13×2020-12-31
2021-04-302,908×2020-12-31
2021-05-282,003.22×2021-03-31
2021-06-302,039.18×2021-03-31
2021-07-302,077.66×2021-03-31
2021-08-31—2021-06-30
2021-09-30—2021-06-30
2021-10-29—2021-06-30
2021-11-30—2021-09-30
2021-12-31—2021-09-30
2022-01-31—2021-09-30
2022-02-281,143.28×2021-12-31
2022-03-311,150.62×2021-12-31
2022-04-291,032.27×2021-12-31
2022-05-31334.38×2022-03-31
2022-06-30341.36×2022-03-31
2022-07-29388.13×2022-03-31
2022-08-31512.09×2022-06-30
2022-09-30459.83×2022-06-30
2022-10-31518.79×2022-06-30
2022-11-301,237×2022-09-30
2022-12-301,216.43×2022-09-30
2023-01-311,187.21×2022-09-30
2023-02-281,141.93×2022-09-30
2023-03-311,317.95×2022-09-30
2023-04-281,314.15×2022-09-30
2023-05-3132,039.71×2023-03-31
2023-06-3033,685.8×2023-03-31
2023-07-3132,331.78×2023-03-31
2023-08-31213.78×2023-06-30
2023-09-29177.85×2023-06-30
2023-10-31147.83×2023-06-30
2023-11-30116.01×2023-09-30
2023-12-29133.12×2023-09-30
2024-01-31117.11×2023-09-30
2024-02-2966.84×2023-12-31
2024-03-2869.86×2023-12-31
2024-04-3070.08×2023-12-31
2024-05-3155.84×2024-03-31
2024-06-2863.59×2024-03-31
2024-07-3161.25×2024-03-31
2024-08-3037.86×2024-06-30
2024-09-3043.45×2024-06-30
2024-10-3143.23×2024-06-30
2024-11-2946.87×2024-09-30
2024-12-3145.87×2024-09-30
2025-01-3148.91×2024-09-30
2025-02-2847.84×2024-09-30
2025-03-3146.14×2024-09-30
2025-04-3044.33×2024-09-30
2025-05-3059.89×2025-03-31
2025-06-3057.89×2025-03-31
2025-07-3153.14×2025-03-31
2025-08-29101.71×2025-06-30
2025-09-3092.39×2025-06-30
2025-10-3193.67×2025-06-30
2025-11-2893.91×2025-09-30
2025-12-3181.58×2025-09-30
2026-01-3073.42×2025-09-30
2026-02-2770.54×2025-12-31
2026-03-3160.02×2025-12-31
2026-04-3049.24×2025-12-31
2026-05-2933.6×2026-03-31
2026-06-3035.3×2026-03-31
2026-07-3138.34×2026-03-31
2026-08-3127.49×2026-06-30
2026-09-2525.17×2026-06-30
Mean 2,053.1×Median 152.57×83% below median

ROIC

% · Annual / TTM

—
Insulet ROIC. Reported fiscal history.
Fiscal period% · Annual / TTM
FY 2011 Q2—
FY 2011 Q3—
FY 2011 Q4—
FY 2012 Q1—
FY 2012 Q2—
FY 2012 Q3—
FY 2012 Q4—
FY 2013 Q1—
FY 2013 Q2—
FY 2013 Q3—
FY 2013 Q4—
FY 2014 Q1—
FY 2014 Q2—
FY 2014 Q3—
FY 2014 Q4—
FY 2015 Q1—
FY 2015 Q2—
FY 2015 Q3—
FY 2015 Q4—
FY 2016 Q1—
FY 2016 Q2—
FY 2016 Q3—
FY 2016 Q4—
FY 2017 Q1—
FY 2017 Q2—
FY 2017 Q3—
FY 2017 Q4—
FY 2018 Q1—
FY 2018 Q2—
FY 2018 Q3—
FY 2018 Q43.02%
FY 2019 Q1—
FY 2019 Q2—
FY 2019 Q3—
FY 2019 Q45.55%
FY 2020 Q1—
FY 2020 Q2—
FY 2020 Q3—
FY 2020 Q44.8%
FY 2021 Q1—
FY 2021 Q2—
FY 2021 Q3—
FY 2021 Q4—
FY 2022 Q1—
FY 2022 Q2—
FY 2022 Q3—
FY 2022 Q4—
FY 2023 Q1—
FY 2023 Q2—
FY 2023 Q3—
FY 2023 Q415.97%
FY 2024 Q1—
FY 2024 Q2—
FY 2024 Q3—
FY 2024 Q4—
FY 2025 Q1—
FY 2025 Q2—
FY 2025 Q3—
FY 2025 Q420.37%
FY 2026 Q1—
FY 2026 Q2—

Capital allocation

% of tracked cash uses

$32.5M
Insulet capital allocation. Quarterly values. Missing values are unavailable.
PeriodCapexAcquisitionsBuybacksDividendsDebt repaymentsTracked uses
FY 2011 Q2100% · $2.663MUnavailableUnavailableUnavailableUnavailable100% · $2.663M
FY 2011 Q3100% · $3.278M0% · $0MUnavailableUnavailable0% · $0M100% · $3.278M
FY 2011 Q4100% · $2.276M0% · $0MUnavailableUnavailableUnavailable100% · $2.276M
FY 2012 Q1100% · $1.699MUnavailableUnavailableUnavailableUnavailable100% · $1.699M
FY 2012 Q2100% · $2.55MUnavailableUnavailableUnavailableUnavailable100% · $2.55M
FY 2012 Q3100% · $4.687MUnavailableUnavailableUnavailable0% · $0M100% · $4.687M
FY 2012 Q4100% · $2.055MUnavailableUnavailableUnavailableUnavailable100% · $2.055M
FY 2013 Q1100% · $1.069MUnavailableUnavailableUnavailableUnavailable100% · $1.069M
FY 2013 Q2100% · $1.626MUnavailableUnavailableUnavailableUnavailable100% · $1.626M
FY 2013 Q3100% · $1.822MUnavailableUnavailableUnavailable0% · $0M100% · $1.822M
FY 2013 Q4100% · $2.79MUnavailableUnavailableUnavailable0% · $0M100% · $2.79M
FY 2014 Q1100% · $2.157MUnavailableUnavailableUnavailableUnavailable100% · $2.157M
FY 2014 Q2100% · $3.588MUnavailableUnavailableUnavailableUnavailable100% · $3.588M
FY 2014 Q39.73% · $3.108MUnavailableUnavailableUnavailable90.27% · $28.836M100% · $31.944M
FY 2014 Q4100% · $2.633MUnavailableUnavailableUnavailable0% · $0M100% · $2.633M
FY 2015 Q1100% · $4.346MUnavailableUnavailableUnavailableUnavailable100% · $4.346M
FY 2015 Q2100% · $0.255MUnavailableUnavailableUnavailableUnavailable100% · $0.255M
FY 2015 Q3100% · $2.525MUnavailableUnavailableUnavailable0% · $0M100% · $2.525M
FY 2015 Q4100% · $3.482MUnavailableUnavailableUnavailable0% · $0M100% · $3.482M
FY 2016 Q1100% · $3.16MUnavailableUnavailableUnavailableUnavailable100% · $3.16M
FY 2016 Q2100% · $2.745MUnavailableUnavailableUnavailableUnavailable100% · $2.745M
FY 2016 Q3100% · $13.3MUnavailableUnavailableUnavailableUnavailable100% · $13.3M
FY 2016 Q4100% · $2.91MUnavailableUnavailableUnavailable0% · $0M100% · $2.91M
FY 2017 Q1100% · $25.679MUnavailableUnavailableUnavailable0% · $0M100% · $25.679M
FY 2017 Q2100% · $13.389MUnavailableUnavailableUnavailable0% · $0M100% · $13.389M
FY 2017 Q3100% · $8.745MUnavailableUnavailableUnavailable0% · $0M100% · $8.745M
FY 2017 Q422.98% · $29.413MUnavailableUnavailableUnavailable77.02% · $98.572M100% · $127.985M
FY 2018 Q198.02% · $35.374MUnavailable1.94% · $0.7MUnavailable0.04% · $0.015M100% · $36.089M
FY 2018 Q288.96% · $54.563MUnavailable0.16% · $0.1MUnavailable10.88% · $6.672M100% · $61.335M
FY 2018 Q399.97% · $37.622MUnavailable0% · $0MUnavailable0.03% · $0.012M100% · $37.634M
FY 2018 Q4100% · $34.795MUnavailableUnavailableUnavailable0% · $0M100% · $34.795M
FY 2019 Q199.34% · $45.255MUnavailable0.66% · $0.3MUnavailable0% · $0M100% · $45.555M
FY 2019 Q2100% · $46.694MUnavailableUnavailableUnavailable0% · $0M100% · $46.694M
FY 2019 Q34.75% · $22.636MUnavailableUnavailableUnavailable95.25% · $453.608M100% · $476.244M
FY 2019 Q418.96% · $49.115MUnavailableUnavailableUnavailable81.04% · $209.992M100% · $259.107M
FY 2020 Q1100% · $26.9MUnavailableUnavailableUnavailableUnavailable100% · $26.9M
FY 2020 Q2100% · $24.8MUnavailableUnavailableUnavailableUnavailable100% · $24.8M
FY 2020 Q3100% · $36.8MUnavailableUnavailableUnavailable0% · $0M100% · $36.8M
FY 2020 Q4100% · $40.5MUnavailableUnavailableUnavailable0% · $0M100% · $40.5M
FY 2021 Q1100% · $32.9MUnavailableUnavailableUnavailableUnavailable100% · $32.9M
FY 2021 Q2100% · $19.9MUnavailableUnavailableUnavailableUnavailable100% · $19.9M
FY 2021 Q3100% · $27.3MUnavailableUnavailableUnavailable0% · $0M100% · $27.3M
FY 2021 Q499.69% · $31.8MUnavailableUnavailableUnavailable0.31% · $0.1M100% · $31.9M
FY 2022 Q1100% · $12.8MUnavailableUnavailableUnavailableUnavailable100% · $12.8M
FY 2022 Q2100% · $14.6MUnavailableUnavailableUnavailableUnavailable100% · $14.6M
FY 2022 Q3100% · $31.1MUnavailableUnavailableUnavailable0% · $0M100% · $31.1M
FY 2022 Q4100% · $64.4MUnavailableUnavailableUnavailable0% · $0M100% · $64.4M
FY 2023 Q1100% · $10.5MUnavailableUnavailableUnavailableUnavailable100% · $10.5M
FY 2023 Q2100% · $15.7MUnavailableUnavailableUnavailableUnavailable100% · $15.7M
FY 2023 Q3100% · $20.1MUnavailableUnavailableUnavailableUnavailable100% · $20.1M
FY 2023 Q4100% · $29.3MUnavailableUnavailableUnavailableUnavailable100% · $29.3M
FY 2024 Q1100% · $22.1MUnavailableUnavailableUnavailable0% · $0M100% · $22.1M
FY 2024 Q2100% · $22.5MUnavailableUnavailableUnavailable0% · $0M100% · $22.5M
FY 2024 Q3100% · $26.7MUnavailable0% · $0MUnavailable0% · $0M100% · $26.7M
FY 2024 Q4100% · $53.6MUnavailable0% · $0MUnavailable0% · $0M100% · $53.6M
FY 2025 Q16.98% · $12.3MUnavailable0% · $0MUnavailable93.02% · $163.9M100% · $176.2M
FY 2025 Q24.36% · $18.6MUnavailable7.06% · $30.1MUnavailable88.58% · $377.6M100% · $426.3M
FY 2025 Q34.52% · $25.6MUnavailable5.21% · $29.5MUnavailable90.26% · $510.7M100% · $565.8M
FY 2025 Q4100% · $135.1MUnavailable0% · $0MUnavailable0% · $0M100% · $135.1M
FY 2026 Q17.49% · $24.3MUnavailable92.51% · $300MUnavailable0% · $0M100% · $324.3M
FY 2026 Q2100% · $32.5MUnavailable0% · $0MUnavailable0% · $0M100% · $32.5M

Tracked cash uses · SBC excluded

Sources and calculations

Company filings · USD · Last checked 2026-10-18. Missing inputs remain unavailable. Your chart selection and layout are saved in this browser for Insulet.

All charts share the selected dates. Quarterly/Yearly changes fiscal charts; valuation keeps completed daily closes on a published TTM basis. Later restatements can delay that basis. Historical mean, median and pricing labels use the selected range and do not estimate intrinsic fair value.

SBC deduction is an optional economic-cost scenario for FCF-based metrics. Missing SBC never becomes zero.

Revenue
Reported revenue from company filings.
Free cash flow
Operating cash flow − reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Reflects the SBC option and can differ from issuer-defined FCF.
Net margin
Reported net income / revenue × 100.
P/E
Completed closing price × diluted shares / TTM earnings attributable to common shareholders.
ROIC
NOPAT / average invested capital × 100. NOPAT = operating income × (1 − effective tax rate). Invested capital = equity including noncontrolling interests + debt − cash and equivalents. Average uses period end and one year earlier.
Capital allocation
Reported cash uses as a percentage of tracked uses. Missing categories remain unavailable; SBC is noncash and excluded.
Reported revenue and sources